Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT06848556
Eligibility Criteria:
Inclusion Criteria:
* Hepatocellular carcinoma, either histologically/cytologically confirmed or clinically diagnosed
* Age 18-80 years
* Patient is eligible to do TAE or TACE treatment.
* ECOG performance status score 0-1.
* Child-Pugh score 5 - 7 .
* No portal vein tumor thrombus, lymph node metastasis, peritoneal tumor seeding, or extrahepatic metastasis.
Exclusion Criteria:
* Prior liver transplantation
* History of liver tumor embolization or radioembolization
* Uncontrolled HBV or HCV infection
* Significant cardiovascular, pulmonary, or renal disease
* QTc prolongation or use of QTc-prolonging medications
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT06848556
Study Brief:
Protocol Section:
NCT06848556